KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $463,723 | -13.7% | 2,742,457 | +10.6% | 0.33% | -10.4% |
Q2 2023 | $537,579 | +19.3% | 2,479,035 | -0.1% | 0.37% | +13.3% |
Q1 2023 | $450,607 | +90.7% | 2,480,765 | +106.3% | 0.32% | +78.5% |
Q4 2022 | $236,317 | -99.9% | 1,202,631 | +23.6% | 0.18% | +3.4% |
Q3 2022 | $218,915,000 | – | 973,257 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |